Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 P108 | DOI: 10.1530/endoabs.99.P108

ECE2024 Poster Presentations Pituitary and Neuroendocrinology (120 abstracts)

Soluble α-klotho protein, nesfatin-1 and IGFBP-3 concentrations in the biochemical diagnosis and monitoring treatment effects in patients with acromegaly

Magdalena Ostrowska 1 , Wojciech Zgliczyński 1 & Piotr Glinicki 1,2


1Department of Endocrinology, Centre of Postgraduate Medical Education, Warsaw, Poland; 2EndoLab Laboratory, Centre of Postgraduate Medical Education, Warsaw, Poland


Introduction: Active acromegaly is diagnosed based on clinical symptoms and biochemical tests, such as elevated GH concentration, IGF-1 concentration above the reference range for sex and age. However, due to certain limitations associated with IGF-1 measurements, alternative biomarkers are being sought that may be useful at various stages of the diagnostic and therapeutic process.

Purpose: Evaluation of the usefulness of serum soluble α-klotho protein, nesfatin-1 and IGFBP-3 determination in the biochemical diagnosis and treatment monitoring in patients with acromegaly.

Materials and Methods: The concentrations of soluble α-klotho protein, nesfatin-1 and IGFBP-3 were determined in patients at the time of acromegaly diagnosis, as well as after 3 and 12 months following the removal of the pituitary adenoma. The examined biomarkers were measured in 35 patients at the time of diagnosis and in 25 patients after 3 and 12 months post-surgery. Measurements of soluble α-klotho protein and nesfatin-1 were conducted using the ELISA immunoassay, while IGFBP-3 was determined using the isotopic method (RIA immunoassay).

Results: The concentration of soluble α-klotho protein was higher (P=0.0001) at the time of disease diagnosis compared to the control group. However, no difference was observed in the soluble α-klotho protein concentration at 3 and 12 months after surgery in the study group (P=0.214) vs the control group (P=0.407). The concentration of soluble α-klotho protein was lower (P=0.0001) 3 months after surgery than at the time of disease diagnosis. No difference was observed in the concentration of soluble α-klotho protein at 3 and 12 months after surgery (P=0.802). The IGFBP-3 concentration was lower (P=0.0001) at 3 and 12 months after surgery than at the time of disease diagnosis (P=0.0001). No differences were observed in the IGFBP-3 concentration at 3 and 12 months after surgery (P=0.122).

Conclusion: Determination of concentrations of the biomarkers tested: soluble α-klotho protein and IGFBP-3, may be useful in the diagnosis of patients with acromegaly. The concentration of nesfatin-1 did not show discriminatory properties in patients with acromegaly.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.